CD52 knockdown inhibits aerobic glycolysis and malignant behavior of NSCLC cells through AKT signaling pathway
Article in Journal of Cancer (April 2024)
The most recent citing publications are shown below. View all 269 publications that cite this research output on Dimensions.
Article in Journal of Cancer (April 2024)
Article in Biomedical Materials (April 2024)
Article in Drug Delivery and Translational Research (April 2024)